Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Consolidated Net Income (2016 - 2026)

Bio-Techne has reported Consolidated Net Income over the past 17 years, most recently at $38.0 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 8.94% year-over-year to $38.0 million; the TTM value through Dec 2025 reached -$5.7 million, down 103.88%, while the annual FY2025 figure was -$13.4 million, 108.53% down from the prior year.
  • Consolidated Net Income for Q4 2025 was $38.0 million at Bio-Techne, roughly flat from $38.2 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $89.7 million in Q3 2022 and troughed at -$193.2 million in Q2 2022.
  • A 5-year average of $23.2 million and a median of $41.8 million in 2021 define the central range for Consolidated Net Income.
  • Biggest five-year swings in Consolidated Net Income: skyrocketed 123.65% in 2023 and later plummeted 451.77% in 2025.
  • Year by year, Consolidated Net Income stood at $72.1 million in 2021, then tumbled by 30.61% to $50.0 million in 2022, then plummeted by 45.08% to $27.5 million in 2023, then grew by 27.03% to $34.9 million in 2024, then grew by 8.94% to $38.0 million in 2025.
  • Business Quant data shows Consolidated Net Income for TECH at $38.0 million in Q4 2025, $38.2 million in Q3 2025, and -$104.5 million in Q2 2025.